Zacks Investment Research on MSN
Pfizer stock slides despite Q4 earnings beat and new obesity drug data
Pfizer PFE reported fourth-quarter 2025 adjusted earnings per share of 66 cents, which comprehensively beat the Zacks Consensus Estimate of 57 cents per share. Earnings rose 5% year over year.
China, the country at the epicentre of the coronavirus pandemic, now sees few cases and deaths. How has it done it and are the official numbers trustworthy? Promising early results from vaccine trials ...
ETHealthworld.com brings latest covid 19 shots news, views and updates from all top sources for the Indian Health industry.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果